Activation of Neutrophils via IP3 Pathway Following Exposure to Demodex-Associated Bacterial Proteins
- 283 Downloads
- 6 Citations
Abstract
Rosacea is a chronic inflammatory condition that predominantly affects the skin of the face. Sera from rosacea patients display elevated reactivity to proteins from a bacterium (Bacillus oleronius) originally isolated from a Demodex mite from a rosacea patient suggesting a possible role for bacteria in the induction and persistence of this condition. This work investigated the ability of B. oleronius proteins to activate neutrophils and demonstrated activation via the IP3 pathway. Activated neutrophils displayed increased levels of IP1 production, F-actin formation, chemotaxis, and production of the pro-inflammatory cytokines IL-1β and IL-6 following stimulation by pure and crude B. oleronius protein preparations (2 μg/ml), respectively. In addition, neutrophils exposed to pure and crude B. oleronius proteins (2 μg/ml) demonstrated increased release of internally stored calcium (Ca2+), a hallmark of the IP3 pathway of neutrophil activation. Neutrophils play a significant role in the inflammation associated with rosacea, and this work demonstrates how B. oleronius proteins can induce neutrophil recruitment and activation.
KEY WORDS
Bacillus Demodex inflammation neutrophils rosaceaNotes
Acknowledgments
F. McM is funded by the Programme in BioAnalysis and Therapeutics (BioAT) by the Higher Education Authority of Ireland through PRTLI V.
Compliance with Ethical Standards
Conflict of interest
S. Paulie is employed by, and part-owner of, Mabtech AB. C. Smedman is employed by Mabtech AB. The other authors (F.McMahon, N. Banville, D. Bergin, E. Reeves, K. Kavanagh) have no conflicts of interest to declare.
Supplementary material
References
- 1.Powell, F.C. 2005. Rosacea. New England Journal of Medicine 352: 793–803.CrossRefPubMedGoogle Scholar
- 2.Holmes, A.D. 2013. Potential role of microorganisms in the pathogenesis of rosacea. Journal of American Academy of Dermatology 69: 1025–32.CrossRefGoogle Scholar
- 3.Jarmuda, S., N. O'Reilly, R. Zaba, O. Jakubowicz, A. Szkaradkiewicz, and K. Kavanagh. 2012. The potential role of Demodex folliculorum mites and bacteria in the induction of rosacea. Journal of Medical Microbiology 61: 1504–10.CrossRefPubMedGoogle Scholar
- 4.Wilkin, J., M. Dahl, M. Detmar, L. Drake, A. Feinstein, R. Odom, and F. Powell. 2002. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. Journal of American Academy of Dermatology 46: 584–87.CrossRefGoogle Scholar
- 5.Crawford, G.H., M.T. Pelle, and W.D. James. 2004. Rosacea: I. Etiology, pathogenesis, and subtype classification. Journal of American Academy of Dermatology 51: 327–41.CrossRefGoogle Scholar
- 6.Gupta, A.K., and M.M. Chaudhry. 2005. Rosacea and its management: an overview. Journal of the European Academy of Dermatology and Venereology 19: 273–85.CrossRefPubMedGoogle Scholar
- 7.Pelle, M.T., G.H. Crawford, and W.D. James. 2004. Rosacea: II. Therapy. Journal of American Academy of Dermatology 51: 499–512.CrossRefGoogle Scholar
- 8.Yamasaki, K., and R.L. Gallo. 2009. The molecular pathology of rosacea. Journal of Dermatological Science 55: 77–81.PubMedCentralCrossRefPubMedGoogle Scholar
- 9.Akamatsu, H., M. Oguchi, S. Nishijima, Y. Asada, M. Takashi, T. Ushijima, and Y. Niwa. 1990. The inhibition of free radical generation by human neutrophils through the synergistic effect of metronidazole with palmitoleic acid: a possible mechanism of metronidazole in rosacea and acne. Archives of Dermatological Research 282: 449–54.CrossRefPubMedGoogle Scholar
- 10.Miyashi, Y., A. Yoshioka, S. Imamura, and Y. Niwa. 1986. Effect of antibiotics on the generation of reactive oxygen species. Journal of Investigative Dermatology 86: 449–53.CrossRefGoogle Scholar
- 11.Yoshioka, A., Y. Miyachi, S. Imamura, and Y. Niwa. 1986. Anti-oxidant effects of retinoids on inflammatory skin diseases. Archives of Dermatological Research 278: 177–83.CrossRefPubMedGoogle Scholar
- 12.Starkey, P.M., A.J. Barrett, and M.C. Burleigh. 1977. The degradation of articular collagen by neutrophil proteinases. Biochimica et Biophysica Acta 483: 386–97.CrossRefPubMedGoogle Scholar
- 13.Berton, A., G. Godeau, H. Emonard, K. Baba, P. Bellon, W. Hornebeck, and G. Bellon. 2000. Analysis of the ex vivo specificity of human gelatinases A and B towards skin collagen and elastic fibers by computerized morphometry. Matrix Biology 19: 139–148.CrossRefPubMedGoogle Scholar
- 14.Devaney, J.M., C.M. Greene, C.C. Taggart, T.P. Carroll, S.J. O’Neill, and N.G. McElvaney. 2003. Neutrophil elastase up-regulates interleukin-8 via toll-like receptor 4. FEBS Letters 544: 129–132.CrossRefPubMedGoogle Scholar
- 15.Kuwahara, I., E.P. Lillehoj, W. Lu, I.S. Singh, Y. Isohama, T. Miyata, and K.C. Kim. 2006. Neutrophil elastase induces IL-8 gene transcription and protein release through p38/NF-κB activation via EGFR trans-activation in a lung epithelial cell line. American Journal of Physiology. Lung Cellular and Molecular Physiology 291: 407–416.CrossRefGoogle Scholar
- 16.Tintinger, G., H.C. Steel, and R. Anderson. 2005. Taming the neutrophil: calcium clearance and influx mechanisms as novel targets for pharmacological control. Clinical Experimental Immunology 141: 191–200.PubMedCentralCrossRefPubMedGoogle Scholar
- 17.Bokoch, G.M. 1995. Chemoattractant signaling and leukocyte activation. Blood 86: 1649–1660.PubMedGoogle Scholar
- 18.Binah, O., M. Shilkrut, G. Yaniv, and S. Larisch. 2004. The Fas receptor 1,4,5-IP3 cascade: a potential target for treating heart failure and arrhythmias. Annals of the New York Academy of Science 1015: 338–350.CrossRefGoogle Scholar
- 19.Wacker, M.J., L.M. Kosloski, W.J.R. Gilbert, C.D. Touchberry, D.S. Moore, J.K. Kelly, M. Brotto, and J.A. Orr. 2009. Inhibition of thromboxane A2-induced arrhythmias and intracellular calcium changes in cardiac myocytes by blockade of the inositol trisphosphate pathway. Journal of Pharmacological and Experimental Therapeutics 331: 917–924.CrossRefGoogle Scholar
- 20.Vance, J. 1986. Demodicidosis – Do Demodex mites cause Disease? Current Concepts in Skin Disorder 10–18.Google Scholar
- 21.Bonner, E., P. Eustace, and F.C. Powell. 1993. The Demodex mite population in Rosacea. Journal of American Academy of Dermatology 28: 443–448.CrossRefGoogle Scholar
- 22.Erbağci, Z., and O. Ozgöztaşi. 1998. The significance of Demodex folliculorum density in rosacea. International Journal of Dermatology 37: 421–425.CrossRefPubMedGoogle Scholar
- 23.Ni Raghallaigh, S., K. Bender, N. Lacey, L. Brennan, and F.C. Powell. 2012. The fatty acid profile of the skin surface lipid layer in papulopustular rosacea. British Journal of Dermatology 166: 279–287.CrossRefPubMedGoogle Scholar
- 24.Dahl, M.V., A.J. Ross, and P.M. Schlievert. 2004. Temperature regulates bacterial protein production: possible role in rosacea. Journal of American Academy of Dermatology 50: 266–272.CrossRefGoogle Scholar
- 25.Lacey, N., S. Delaney, K. Kavanagh, and F.C. Powell. 2007. Mite-related bacterial antigens stimulate inflammatory cells in rosacea. British Journal of Dermatology 157: 474–481.CrossRefPubMedGoogle Scholar
- 26.Whitfeld, M., N. Gunasingam, L. Joo Leow, K. Shirato, and V. Preda. 2011. Staphylococcus epidermidis: a possible role in the pustules of rosacea. Journal of American Academy of Dermatology 64: 49–52.CrossRefGoogle Scholar
- 27.Kuhnigk, T., E.M. Borst, A. Breunig, H. König, M.D. Collins, R.A. Hutson, and P. Kämpfer. 1995. Bacillus oleronius sp. nov., a member of the hind-gut flora of the termite Reticulitermes santonensis (Feytaud). Canadian Journal of Microbiology 41: 699–706.CrossRefPubMedGoogle Scholar
- 28.Szkaradkiewicz, A., I. Chudzicka-Strugała, T.M. Karpiński, O. Goślińska-Pawłowska, T. Tułecka, W. Chudzicki, A.K. Szkaradkiewicz, and R. Zaba. 2012. Bacillus oleronius and Demodex mite infestation in patients with chronic blepharitis. Clinical Microbiology and Infection 18: 1020–1025.CrossRefPubMedGoogle Scholar
- 29.Li, J., N. O'Reilly, H. Sheha, R. Katz, V.K. Raju, K. Kavanagh, and S.C. Tseng. 2010. Correlation between ocular Demodex infestation and serum immunoreactivity to Bacillus microbial proteins in patients with facial rosacea. Ophthalmology 117: 870–877.PubMedCentralCrossRefPubMedGoogle Scholar
- 30.O’Reilly, N., N. Menezes, and K. Kavanagh. 2012. Positive correlation between serum immuno-reactivity to Demodex-associated Bacillus proteins and erythematotelangiectic rosacea. British Journal of Dermatology 167: 1032–1036.CrossRefPubMedGoogle Scholar
- 31.Jarmuda, S., F. McMahon, R. Zaba, N. O’Reilly, O. Jakubowicz, A. Holland, A. Szkaradkiewicz, and K. Kavanagh. 2014. Correlation between serum reactivity to Demodex-associated Bacillus oleronius proteins, and altered sebum levels and Demodex populations in erythematotelangiectatic rosacea patients. Journal of Medical Microbiology 63: 258–262.CrossRefPubMedGoogle Scholar
- 32.O’Reilly, N., C. Gallagher, K.R. Katikireddy, M. Clynes, F. O’Sullivan, and K. Kavanagh. 2012. Demodex-associated Bacillus proteins induce an aberrant wound healing response in a corneal epithelial cell line (hTCEpi): possible implications for corneal ulcer formation in ocular rosacea. Investigative Ophthalmology and Visual Science 53: 3250–3259.CrossRefPubMedGoogle Scholar
- 33.McMahon, F.W., C. Gallagher, N. O’Reilly, M. Clynes, F. O’Sullivan, and K. Kavanagh. 2014. Exposure of a corneal epithelial cell line (hTCEpi) to Demodex-associated Bacillus proteins results in an inflammatory response. Investigative Ophthalmology and Visual Science 55: 7019–7028.CrossRefPubMedGoogle Scholar
- 34.O’Reilly, N., D. Bergin, E.P. Reeves, N.G. McElvaney, and K. Kavanagh. 2012. Demodex-associated bacterial proteins induce neutrophil activation. British Journal of Dermatology 166: 753–760.CrossRefPubMedGoogle Scholar
- 35.Reeves, E.P., H. Lu, H.L. Jacobs, C.G. Messina, S. Bolsover, G. Gabella, E.O. Potma, A. Warley, J. Roes, and A.W. Segal. 2002. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature 416: 291–297.CrossRefPubMedGoogle Scholar
- 36.Eichner, R.D., M. Al Salami, P.R. Wood, and A. Müllbacher. 1986. The effect of gliotoxin upon macrophage function. International Journal of Immunopharmacology 8: 789–797.CrossRefPubMedGoogle Scholar
- 37.Jayachandran, R., V. Sundaramurthy, B. Combaluzier, P. Mueller, H. Korf, K. Huygen, T. Miyazaki, I. Albrecht, J. Massner, and J. Pieters. 2007. Survival of mycobacteria in macrophages is mediated by coronin 1-dependent activation of calcineurin. Cell 130: 37–50.CrossRefPubMedGoogle Scholar
- 38.Rossi, F. 1986. The O2-forming NADPH oxidase of the phagocytes: Nature, mechanisms of activation and function. Biochimica et Biophysica Acta 853: 65–89.CrossRefPubMedGoogle Scholar
- 39.Lew, P.D. 1990. Receptors and intracellular signaling in human neutrophils. The American Review of Respiratory Disease 141: S127–131.CrossRefPubMedGoogle Scholar
- 40.Billah, M.M. 1993. Phospholipase D and cell signaling. Current Opinions in Immunology 5: 114–123.CrossRefGoogle Scholar
- 41.Thelen, M., and U. Wirthmueller. 1994. Phospholipases and protein kinases during phagocyte activation. Current Opinions in Immunology 6: 106–112.CrossRefGoogle Scholar
- 42.Pollard, T.D., and J.A. Cooper. 2009. Actin, a central player in cell shape and movement. Science 326: 1208–1212.PubMedCentralCrossRefPubMedGoogle Scholar
- 43.Brink, N., M. Szamel, A.R. Young, K.P. Wittern, and J. Bergemann. 2000. Comparative quantification of IL-1beta, IL-10, IL-10r, TNFalpha and IL-7 mRNA levels in UV-irradiated human skin in vivo. Inflammation Research 49: 290–296.CrossRefPubMedGoogle Scholar
- 44.Grossman, R.M., J. Krueger, D. Yourish, A. Granelli-Piperno, D.P. Murphy, L.T. May, T.S. Kupper, P.B. Sehgal, and A.B. Gottlieb. 1989. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proceedings of the National Academy of Science of the USA 86: 6367–6371.CrossRefGoogle Scholar
- 45.Aylesworth, R., and J.C. Vance. 1982. Demodex folliculorum and Demodex brevis in cutaneous biopsies. Journal of American Academy of Dermatology 7: 583–589.CrossRefGoogle Scholar
- 46.Akilov, O.E., and K.Y. Mumcuoglu. 2003. Association between human demodicosis and HLA class I. Clinical and Experimental Dermatology 28: 70–73.CrossRefPubMedGoogle Scholar
- 47.Casas, C., C. Paul, M. Lahfa, B. Livideanu, O. Lejeune, S. Alvarez-Georges, C. Saint-Martory, A. Degouy, V. Mengeaud, H. Ginisty, E. Durbise, A.M. Schmitt, and D. Redoulès. 2012. Quantification of Demodex folliculorum by PCR in rosacea and its relationship to skin innate immune activation. Experimental Dermatology 21: 906–910.CrossRefPubMedGoogle Scholar
- 48.Grice, E.A., and J.A. Segre. 2011. The skin microbiome. Nature Reviews Microbiology 9: 244–253.PubMedCentralCrossRefPubMedGoogle Scholar
- 49.Leyden, J.J., K.J. McGinley, O.H. Mills, and A.M. Kligman. 1975. Propionibacterium levels in patients with and without acne vulgaris. Journal of Investigative Dermatology 65: 382–384.CrossRefPubMedGoogle Scholar
- 50.Somerville, D.A. 1969. The normal flora of the skin in different age groups. British Journal of Dermatology 81: 248–258.CrossRefPubMedGoogle Scholar
- 51.Murillo, N., J. Aubert, and D. Raoult. 2014. Microbiota of Demodex mites from rosacea patients and controls. Microbial Pathogenesis 71–72: 37–40.CrossRefPubMedGoogle Scholar
- 52.Putney, J.W. 2007. Recent breakthroughs in the molecular mechanism of capacitative calcium entry (with thoughts on how we got here). Cell Calcium 42: 103–110.PubMedCentralCrossRefPubMedGoogle Scholar
- 53.Berridge, M.J. 1995. Capacitative calcium entry. Biochemistry Journal 312: 1–11.CrossRefGoogle Scholar
- 54.Taylor, C.W., P.C. da Fonseca, and E.P. Morris. 2004. IP3 receptors: the search for structure. Trends in Biochemical Science 29: 210–219.CrossRefGoogle Scholar
- 55.Lawrence, T. 2009. The nuclear factor NF-κB pathway in inflammation. Cold Spring Harbor Perspectives in Biology 1(6): a001651.PubMedCentralCrossRefPubMedGoogle Scholar
- 56.Mastrofrancesco, A., M. Ottaviani, N. Aspite, G. Cardinali, E. Izzo, K. Graupe, C.C. Zouboulis, E. Camera, and M. Picardo. 2010. Azelaic acid modulates the inflammatory response in normal human keratinocytes through PPARγ activation. Experimental Dermatology 19: 813–820.CrossRefPubMedGoogle Scholar
- 57.Eishingdrelo, H., and S. Kongsamut. 2013. Minireview: targeting GPCR activated ERK pathways for drug discovery. Current Chemical Genomics and Translational Medicine 7: 9–15.PubMedCentralCrossRefPubMedGoogle Scholar
- 58.Brown, K.M., and D.K. Tracy. 2013. Lithium: the pharmacodynamic actions of the amazing ion. Therapeutic Advances in Psychopharmacology 3: 163–176.PubMedCentralCrossRefPubMedGoogle Scholar
- 59.Kliem, C., A. Merling, M. Giaisi, R. Köhler, P.H. Krammer, and M. Li-Weber. 2012. Curcumin suppresses T cell activation by blocking Ca2+ mobilization and nuclear factor of activated T cells (NFAT) activation. Journal of Biological Chemistry 287: 10200–10209.PubMedCentralCrossRefPubMedGoogle Scholar
- 60.Galeotti, N., A. Bartolini, M. Calvani, R. Nicolai, and C. Ghelardini. 2004. Acetyl-L-carnitine requires phospholipase C-IP3 pathway activation to induce antinociception. Neuropharmacology 47: 286–294.CrossRefPubMedGoogle Scholar